Anastassia Amaro, MD

Obesity Medicine, Diabetes, Endocrinology
Accepting new patients
Sees patients age 18 and up
Penn Endocrinology Perelman
View 3 additional locations
Headshot of Anastassia Amaro, MD
Penn Medicine Provider

About me

  • Medical Director, Penn Metabolic Medicine
  • Professor of Clinical Medicine (Endocrinology, Diabetes and Metabolism)

My education and training

  • Medical School: First Moscow Sechenov Medical Institute
  • Residency: First Moscow Sechenov Medical Institute
  • Residency: Advocate Lutheran General Hospital
  • Fellowship: Barnes-Jewish Center for Outpatient Health

Spoken languages

English
English

Reviews

Average Rating

438 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
June 2026
long time patient, very pleased
Anonymous
June 2026
she is great. takes the time to discuss the science behind t1d.
Anonymous
June 2026
she is very attentive and good person.
Anonymous
June 2026
she makes you feel taken care of.

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Amaro is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Jena S. Tronieri, Kelly C. Allison, Katie DeRouen, Anastasia Amaro, Kayla G. Collins, Anokha Roy, Sanaiya Watts, Tasnia Ananna, Thomas A. Wadden Short- and Long-term Effects of Semaglutide 2.4 mg on Energy Intake, Appetite, and Food Reward: A 60-week, Double-Blind Randomized Controlled Trial , The American Journal of Clinical Nutrition: 2026


Authors: Ryan R. Armbruster, Neil E. Wilson, Yvette Frimpong, Anne Cappola, Anastassia Amaro, Ravinder Reddy CrCEST Measures OXPHOS Improvement and Creatine Decrease following GLP-1 induced weight loss at 7T with 1H-MRS , Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition: 2026


Tang H, Zhang B, Lu Y, Lu Y, Amaro A, Lu Y, Wolk DA, Chen Y. Patterns and Trends of Glucose-Lowering Therapy in Alzheimer's Disease and Related Dementias , Diabetes Obesity Metabolism: 2026


Salvatore M, Zhang B, Tang H, Lu Y, Zhang D, Zhou T, Lu Y, Amaro A, D Ritchie M, Chen Y. Phenome-wide analysis of downstream health outcomes following second-line antidiabetic agent prescriptions in All of Us. , Nature Communications: 2026


Ryan R. Armbruster, Neil E. Wilson, Aylin Ergin, Anne Cappola, Anastassia Amaro, Ravinder Reddy Lipid and Acetyl Carnitine Differences measured before and after GLP-1 induced weight loss at 7T with 1H-MRS , Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition: 2026


Conte, C., Amaro, A. Pharmacologic Treatment of Obesity in the Context of Type 2 Diabetes , Curr Diab Rep : 2026


Wonkyung Choi, Young-Hoon Nho, Liming Qiu, Andrew Chang, Gustavo Campos, Robert L. Seilheimer, W. Bryan Wilent, David Bakalov, Nida Firdous, Marie Kerr, Disha Joshi, Gabriella Maze, Uros Topalovic, Daniel Batista, Nanthia Suthana, Anastassia Amaro, Matthew R. Hayes, Iahn Cajigas, Mario Cristancho, Kelly C. Allison, Bijan Pesaran, Katherine W. Scangos, Joshua I. Gold, Thomas A. Wadden & Casey H. Halpern Brain activity associated with breakthrough food preoccupation in an individual on tirzepatide , Nature Medicine: 2025


Marianne Riordan, Anastassia Amaro Glucagon-Like Peptide-1 Receptor Agonists in Post-Bariatric Hypoglycemia: A Retrospective Chart Review , 32nd European Congress on Obesity: 2025


Caturano A, Amaro A, Berra CC, Conte C. Sarcopenic obesity and weight loss-induced muscle mass loss , Curr Opin Clin Nutr Metab Care: 2025


Emily Gleason, BA Lindsay Levine, BA ∙ Iris T. Lee, MD MSCE ∙ Nathanael Koelper, MPH ∙ Anastassia Amaro, MD ∙ Anuja Dokras, MD, MHCI, PhD Effect of Glucagon-Like Peptide 1 Agonist Medications on Weight Loss in Patients with and Without Polycystic Ovary Syndrome , Fertility and Sterility: 2025